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The relationship between the expression of mitochondrial voltage-dependent anion channels (VDACs) and the protective eﬀects
of Myrica rubra Sieb. Et Zucc fruit extract (MCE) against carbon tetrachloride (CCl4)-induced liver damage was investigated.
Pretreatment with 50 mg kg−1, 150 mg kg−1 or 450 mg kg−1 MCE significantly blocked the CCl4-induced increase in both serum
aspartate aminotransferase (sAST) and serum alanine aminotransferase (sALT) levels in mice (P < .05 or .01 versus CCl4 group).
Ultrastructural observations of decreased nuclear condensation, ameliorated mitochondrial fragmentation of the cristae and less
lipid deposition by an electron microscope confirmed the hepatoprotection. The mitochondrial membrane potential dropped
from −191.94 ± 8.84 mV to −132.06 ± 12.26 mV (P < .01) after the mice had been treated with CCl4. MCE attenuated CCl4-
induced mitochondrial membrane potential dissipation in a dose-dependent manner. At a dose of 150 or 450 mg kg−1 of MCE,
the mitochondrial membrane potentials were restored (P < .05). Pretreatment with MCE also prevented the elevation of intra-
mitochondrial free calcium as observed in the liver of the CCl4-insulted mice (P < .01 versus CCl4 group). In addition, MCE
treatment (50–450 mg kg−1) significantly increased both transcription and translation of VDAC inhibited by CCl4. The above data
suggest that MCE mitigates the damage to liver mitochondria induced by CCl4, possibly through the regulation of mitochondrial
VDAC, one of the most important proteins in the mitochondrial outer membrane.
1. Introduction
Myrica rubra Sieb. Et Zucc. is a myricaceae plant broadly
distributed in eastern Asia. The leaves, bark and fruits of the
tree have been used as astringent, antidote, and antidiarrhetic
in traditional Chinese medicine [1, 2]. Several flavonoids,
tannins [3], triterpenes [4] and diarylheptanoids [1, 5]
have been isolated from the bark of M. rubra previously.
In the pharmacological studies of this natural medicine,
it has been reported that the extract of M. rubra bark
exerts hepatoprotection [6, 7], inhibits melanin biosynthesis
activities [8] and could prevent carcinogenesis [9]. But the
hepatoprotective eﬀects of M. rubra fruits are not well
investigated.
Liver injuries induced by carbon tetrachloride (CCl4)
are the best-characterized system of xenobiotic-induced
hepatotoxicity and commonly used models for the screening
of antihepatotoxic and/or hepatoprotective activities of drugs
[10]. CCl4 causes mitochondrial stress, which activates
signaling cascades involving the activation of caspases,
resulting in apoptosis or necrosis. It is known recently that
mitochondria in cells not only provide ATP by oxidative
phosphorylation but also play many other roles, such as
modulation of intracellular Ca2+ homeostasis, pH control
and induction of apoptotic and excitotoxic cell death [11,
12]. There is accumulated evidence that mitochondrial
permeability transition pore (PTP) plays a key role in
modulating apoptotic and excitotoxic cell death. As a part of
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the outer membrane of mitochondria, the voltage-dependent
anion channel (VDAC) is an important protein that regulates
basic mitochondrial functions as well as the initiation of
apoptosis via the release of intermembrane space proteins
[13]. Our previous studies showed that both transcription
and translation of liver VDAC changed significantly and both
accompanied the mitochondrial damage in liver-damaged
mice, which could be prevented by natural products [14].
In the present study, we evaluated the hepatoprotective
eﬀect of M. rubra Sieb. Et Zucc. extract (MCE) against liver
injury induced by CCl4, addressing the possible action of
MCE on liver mitochondrial and VDAC expression in order
to search for the mechanism underlying its hepatoprotective
activity.
2. Methods
2.1. Plant Material. The chloroform extract of the fresh fruit
of M. rubra—cultivated in Zhe Jiang province, China, and
identified by Dr Yunzhi Zhu, Life Science College, Nanjing
Agricutural University—was used in this study. Briefly, 2 kg
of the fresh fruit was used for the chloroform extraction. It
was prepared by adding solvents, namely petroleum ether,
chloroform, ethyl acetate, n-butanol and water (Figure 1), in
an increasing order of solvent polarity. After filtering through
folded filter paper (Whatman No. 1), the supernatant in
diﬀerent solvents was recovered and this process was repeated
thrice for each solvent. Then the respective solvents from the
supernatant were evaporated in a vacuum rotary evaporator
to obtain a crude extract. The dried form of the chloroform
extract (MCE, 4.486 g) dissolved in 0.9% NaCl was used
orally for checking of the hepatoprotective activities in mice.
2.2. Chemicals. Rhodamine123 (Rh123), succinate, rotenone
and anti-VDAC antibody were purchased from Sigma (St
Louis, MO, USA). RNAiso reagent, dNTP and Taq poly-
merase were from TaKaRa Biotechnology Co., Ltd. M-MLV
reverse transcriptase was from Invitrogene. RNase inhibitor
and Oligo(dT)15 were from Promega. All other chemicals
were of high purity from commercial sources.
2.3. Animals. Male ICR mice (Experiment Animal Center
of Yangzhou University, Yangzhou, China, Certificate No.
SCXK 2003-0002), each weighing 18–22 g, were used. All
animals were fed a standard diet ad libitum and housed
at a temperature of 20–25◦C under 12-h light-dark cycles
throughout the experiment. All mice were acclimatized to
the experimental conditions for 2 days before the start of the
experiment, and they were randomly assigned to any one of
the five groups. The Animal Ethics Committee of the Nanjing
University approved the use of animals for this study.
2.4. CCl4-Induced Hepatotoxicity in Mice. Mice were allo-
cated to any one of the five groups, each with eight animals.
All mice except the normal ones received 0.30% of CCl4
(in olive oil, 10 mL kg−1 intraperitoneally, i.p.). The normal
and CCl4 groups respectively received olive oil (10 mL kg−1
i.p.) and CCl4 following 5 days of oral treatment with saline
Fresh fruits (2 kg)
Extraction with petroleum ether
(thrice) by reflux for 1.5 hours
Extraction with chloroform (thrice)
by reflux for 1.5 hours
Extraction with n-butanol (thrice)
by reflux for 1.5 hours
Extraction with water (thrice)
by reflux for 1.5 hours
Extraction with ethyl acetate (thrice)
by reflux for 1.5 hours
Residue Petroleum ether extract
Chloroform extract (MCE: 4.48)Residue
Residue Ethyl acetate extract
n-butanol extract
Water extract
Residue
Residue
Figure 1: Reflux extraction of fresh fruit of M. rubra Sieb. Et Zucc.
by increasing order of solvent polarity.
[15, 16]. The drug groups received CCl4 following 5 days of
oral treatment with MCEL, MCEM, and MCEH, representing
50, 150, or 450 mg kg−1 MCE [17, 18]. Mice were humanely
killed 24 h after the administration of CCl4 and their
blood was collected. Serum was separated by centrifugation,
and serum aspartate aminotransferase (sAST) and serum
alanine aminotransferase (sALT) activities were estimated
spectrophotometrically. After blood draining, the liver sec-
tions were taken and fixed in 4% neutral-buﬀered formalin
or in 4% glutaraldehyde containing 3% paraformaldehyde,
and prepared for examination under a photomicroscope
or electron microscope (JEM-1200EX) following standard
techniques. The remaining liver lobes intended for mRNA
and protein analyses were frozen immediately and stored in
liquid nitrogen before extraction.
2.5. Isolation of Liver Mitochondria. Mitochondria were pre-
pared from mouse livers according to the method of Aprille
[19]. In brief, mouse livers were excised and homogenized
in isolation buﬀer containing 225 mM d-mannitol, 75 mM
sucrose, 0.05 mM EDTA, and 10 mM Tris-HCl (pH 7.4) at
4◦C. The homogenates were centrifuged at 600 g for 5 min
and supernatants were centrifuged at 8800 g for 10 min.
The pellet was washed twice with the same buﬀer. Protein
concentration was determined using Coomassie Brilliant
Blue [20].
2.6. Measurement of Mitochondrial Membrane Potential. The
mitochondrial membrane potential (ΔΨm) was evaluated
according to Emaus et al. [21] by the uptake of the
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fluorescent dye rhodamine 123 (Rh123), which accumu-
lates electrophoretically into energized mitochondria in
response to the negative inside membrane potential. Isolated
liver mitochondria were suspended in the assay buﬀer
(0.5 mg protein/mL) containing 225 mM mannitol, 70 mM
sucrose, 5 mM HEPES (N-2-hydroxyethylpiperazine-N-2-
ethanesulfonic acid), pH 7.2. The mitochondrial mem-
brane potential (ΔΨm) was assessed spectrophotometrically
(Hitachi 850) at 25◦C with excitation at 505 nm and
detection at 534 nm after addition of 0.3 μM Rh123. The
membrane potential was calculated by the relationship: m
= −59 log [Rh123]in/[Rh123]out, assuming that the distribu-
tion of Rh123 between mitochondria and medium follows
the Nernst equation [21].
2.7. Measurement of Mitochondrial Free Calcium. Intramito-
chondrial Ca2+ level was assayed by the Ca2+ indicator dye
Fluo-3-acetoxymethyl (AM) ester. Briefly, an aliquot of the
Fluo-3-AM stock solution in DMSO was mixed with an equal
amount of Pluronic (Molecular Probes) and added to the
assay buﬀer consisting HBSS, 20 mM HEPES, pH 7.4, and
2.5 mM probenecid (Molecular Probes) to give a final Fluo-
3 concentration of 10 μM. Pluronic helps to disperse the
nonpolar AM ester in aqueous media, whereas probenecid
(an inhibitor of organic anion transporters) reduces leakage
of Fluo-3.
Liver mitochondria (0.5 mg protein/mL) of all experi-
mental groups were incubated with the fluorescence Fluo-
3-AM for 30 min at 37◦C, and then washed twice to
eliminate any free fluo-3-AM. The final mitochondria pellet
was diluted in the suspension medium to obtain a protein
concentration of 0.5 mg mL−1. Fluorescent intensity (F) of
Fluo-3 loaded mitochondria was recorded on a Hitachi 850
fluorescence spectrometer at an excitation of 485 nm and an
emission of 520 nm. The maximum fluorescsent intensity
Fmax was determined by adding 0.4% Triton X-100 and 1 mM
CaCl2 and Fmin was measured by adding 10 mM EGTA to
the above system. The intra-mitochondrial Ca2+ content was
calculated as follows: Kd (F −Fmin)/(Fmax− F).
2.8. Determination of Mitochondrial Swelling. Mitochondrial
swelling was assessed by measuring the absorbance at
540 nm. Liver mitochondria of all the experimental groups
were prepared in the assay buﬀer (0.5 mg protein/mL)
containing 125 mM sucrose, 50 mM KCl, 2 mM KH2PO4,
10 mM HEPES and 5 mM succinate. The extent of mito-
chondrial swelling was assayed by measuring the decrease
in absorbance (A) at 1, 2, 3, 4, 5, 6, and 7 min after
the addition of 100 μM Ca2+ at 30◦C and the swelling
rate of mitochondrial swelling was calculated as follows:
ΔAdrug/ΔAControl× 100%, ΔA = A0min− A [22].
2.9. Evaluation of VDAC mRNA Level by Reverse
Transcription-Polymerase Chain Reaction Assay. Total RNA
was extracted from livers using RNAiso reagent. Reverse
transcription (RT) was started with 5 μg of total RNA at
37◦C for 50 min in a 20 μL reaction mixture containing 20 U
RNase inhibitor, 0.25 mM each of dNTP, 0.5 μg Oligo(dT)15
and 200 U M-MLV reverse transcriptase. The reaction was
terminated by incubation at 70◦C for 15 min. Polymerase
Chain Reaction (PCR) amplification was performed for 28
cycles, by including 4 μL cDNA by adding 5 mM MgCl2,
2.5 U Taq polymerase, 0.25 mM each dNTP and 5′- and
3′-sequence-specific oligonucleotide primers for VDAC and
β-Actin in 10 × Taq polymerase reaction buﬀer, respectively.
Each PCR cycle was set at 94◦C, 30 s; 55◦C, 50 s; 72◦C, 1 min
and finally at 72◦C, 4 min. The internal standard was set with
β-Actin. The amplified fragments were detected by agarose
gel electrophoresis and visualized by ethidium bromide (EB)
staining. The oligonucleotide primers used were: for VDAC,
sense 5′-GGC TAC GGC TTT GGC TTA AT-3′ and anti-
sense 5′-CCC TCT TGT ACC CTG TCT TGA-3′, yielding
a deduced amplification product of 301 bps; whereas for
β-Actin, sense 5′-AGT GTG ACG TTG ACA TCC GTA-3′
and anti-sense 5′-GCC AGA GCA GTA ATC TCC TTC T-3′′
yielding a deduced amplification product of 112 bps.
2.10. Western Blot Analysis for VDAC. Liver samples were
homogenized in ice-cold lysis buﬀer. Homogenates were
centrifuged at 12 000 g for 10 min and the supernatants were
collected, and the protein concentration was determined
using Coomassie Brilliant Blue. The samples (50 μg per
lane) were dissolved in the sample buﬀer and separated by
12% SDS-polyacrylamide gel electrophoresis (PAGE) gels
and electrophoretically transferred onto a polyvinylidene-
difluoride (PVDF) membrane (Bio-Rad). The membrane
was incubated with VDAC primary antibody (1 : 4000)
and β-Actin antibody (1 : 80 000). The membrane was then
exposed to the enhanced chemiluminescence (ECL) solution.
2.11. Statistical Analysis. Diﬀerences among all groups were
analyzed by one-way analysis of variance (ANOVA), followed
by SNK-q-test; a P value < .05 was accepted as statistically
significant. All experiments were repeated at least three
times.
3. Results
3.1. sAST and sALT Activities. Serum enzyme activity of mice
in the prescriptions of MCE is shown in Table 1. Serum ALT
and AST activities increased remarkably (7.8-fold and 2.0-
fold, resp.) after the CCl4 injection. However, treatment with
various concentrations of MCE (50, 150, and 450 mg kg−1)
blocked the above changes significantly in a dose-dependent
manner, and the elevations in sALT and sAST activities were
almost completely inhibited by MCEH.
3.2. Histological Observation. The histological changes asso-
ciated with the hepatoprotective activity in three prescrip-
tions of MCE basically supported the estimation of the serum
enzyme activities. The livers of the CCl4-intoxicated mice
showed gross necrosis, broad infiltration of the lymphocytes
and Kupﬀer cells around the central vein and loss of cellular
boundary (Figure 2). The histological pattern of the livers
of the mice treated with MCE only showed mild degrees of
necrosis and lymphocyte infiltration. MCEH pretreatment
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Figure 2: Photomicrographs of liver sections taken from mice treated with CCl4 with or without pretreatment with MCE. (a) Normal; (b)
CCl4; (c) CCl4 + MCEL; (d) CCl4 + MCEM; and (e) CCl4 + MCEH.
Table 1: Eﬀect of MCE on CCl4-induced acute liver damage in
mice.
Groups Animals (n)
sALT (enzyme
unit/100 mL
serum)
sAST (enzyme
unit/100 mL
serum)
Normal 8 36.4 ± 8.4 82.1 ± 23.1
CCl4 8 283.3 ± 128.1∗∗ 164.9 ± 41.3∗∗
CCl4 + MCEL 8 198.7 ± 101.9∗† 128.8 ± 40.1†
CCl4 + MCEM 8 148.2 ± 78.4∗† 106.9 ± 47.1††
CCl4 + MCEH 8 33.6 ± 7.6†† 75.4 ± 25.5††
CCl4 + DDB 8 33.5 ± 9.1†† 96.90 ± 32.4††
∗
P < .05 versus Normal, ∗∗P < .01 versus Normal, †P < .05 versus CCl4
group, ††P < .01 versus CCl4 group
significantly prevented CCl4-induced inflammatory infiltra-
tion to the extent almost the same as that in the normal group
(Figure 2).
3.3. Protection on the Ultrastructure of Hepatocytes. Obvi-
ous ultrastructural changes in mouse hepatocytes showing
mitochondrial disintegration, lipid deposition and nuclear
condensation as compared with the control (Figure 3) were
induced by CCl4. However, the structure in mice treated with
MCEL was improved to some extent, and in the MCEH group
the hepatocytes were similar to normal cells (Figure 3).
3.4. Mitochondrial Membrane Potential. Under the present
experimental conditions, the mitochondrial membrane
potential of the normal mice was −191.94 ± 8.84 mV.
This value dropped to −132.06 ± 12.26 mV (P < .01)
after the mice had been intra-peritoneally injected with
CCl4 (Figure 4). MCE attenuated CCl4-induced mitochon-
drial membrane potential dissipation in a dose-dependent
manner. At a dose of 150 or 450 mg kg−1 of MCE, the
mitochondrial membrane potentials were restored (P < .05).
3.5. Intra-Mitochondrial Free Calcium. Measurement of cal-
cium content using the fluorescent probe Flou-3 showed that
intra-mitochondrial free calcium concentration in the CCl4-
intoxicated mice was higher (1.8-fold, P < .05) than that in
the normal mice. However, the elevation in calcium level
induced by CCl4 was significantly inhibited by pretreatment
with MCEL, MCEM or MCEH, and the MCEH group’s mito-
chondrial calcium content was maintained at the normal
level (Figure 5).
3.6. Ca-Induced Mitochondrial Swelling. The swelling of liver
mitochondria, which could be attenuated by treatment with
CCl4, was induced by 100 μM Ca2+. The swelling rates of
MCEL, MCEM and MCEH at 7 min were 43.4%, 66.1%, and
77%, respectively, which were more sensitive than that of
CCl4 (24.3%) (Figure 6).
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Figure 3: Protective eﬀect of MCE on the ultrastructure of hepatocytes induced by CCl4. Mice were divided into five groups: (a) Normal, (b)
CCl4, (c) CCl4 + MCEL, (d) CCl4 + MCEM and (e) CCl4 + MCEH. The CCl4 and diﬀerent MCE groups were administered saline or various
concentrations of MCE orally for 5 days before the intra-peritoneal injection of 0.30% CCl4. Specimens were taken 24 h later and regularly
prepared for examination under an electron microscope (×5000).
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Figure 4: Prevention of MCE on mitochondrial membrane poten-
tial dissipation induced by CCl4. Mice were treated with MCE
for 5 days before pretreatment with CCl4. Liver mitochondria
were isolated and the mitochondrial membrane potential was
determined using Rh123. Each value represents mean ± SD (n =
8). ∗P < .05, ∗∗P < .01, versus Normal; +P < .05 versus CCl4 group.
3.7. Prevention against Reduction of Liver VDAC Expression.
The eﬀect of MCE on VDAC transcription was examined by
RT-PCR. As shown in Figure 7(a), the expression of VDAC
mRNA was detected in the normal group, but a lower level of
VDAC mRNA was detected when the mice were stimulated
with 0.3% CCl4. Furthermore, MCEL, MCEM, and MCEH
significantly blocked the CCl4-stimulated VDAC mRNA
reduction.
MCE up-regulation on VDAC protein expression was
further corroborated by western blot (Figure 7(b)). Normal
mouse livers showed a strong signal for VDAC, and mice
receiving CCl4 alone showed a significant decrease. In
contrast, compared with mice treated with CCl4 alone, in
mice pre-administrated with MCE, a stronger VDAC protein
band occurred 24 h following CCl4 treatment.
4. Discussion
The liver has versatile functions and plays important roles
in metabolism, such as biosynthesis of plasma proteins,
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Figure 5: Eﬀect of MCE on liver mitochondrial calcium content
in mice treated with CCl4. Mice were treated with MCE for 5
days before pretreatment with CCl4. Liver mitochondria were then
isolated and mitochondrial free calcium content was determined
using Fluo-3. MCE showed a dose-dependent suppression of the
CCl4-induced intra-mitochondrial Ca2+ overload. Values represent
mean ± SD (n = 6). ∗P < .01 versus the normal group; +P < .01
versus the CCl4 group.
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Figure 6: Eﬀect of MCE on Ca2+-induced mitochondrial swelling.
CCl4 can decrease the sensitivity in Ca2+-induced mitochondrial
swelling. MCE dose-dependently recuperated this sensitivity. The
curves represent typical recordings from experiments of at least
three diﬀerent mitochondrial preparations.
gluconeogenesis and detoxification. Although the liver has
strong regeneration ability, when cellular loss exceeds a
certain threshold, the insuﬃcient functions cause hepatic
failure, leading to liver disease. Overdose of drug or
ischemia/reperfusion induces necrotic and apoptotic cell
death of hepatocytes and non-parenchymal liver cells. One
promising approach to prevent liver injury or to treat patient
with liver disease is to confer resistance against cell death on
hepatocytes and non-parenchymal cells.
The results of the present study show that 50, 150, or
450 mg kg−1 MCE significantly protects mice against CCl4-
induced hepatotoxicity as demonstrated by its inhibition of
the elevation of sAST and sALT. CCl4-induced acute liver
injury may be initiated by the •CCl3 radical, which is formed
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Figure 7: Eﬀect of MCE on mitochondrial VDAC expression in
CCl4-insulted mouse livers. Livers from various groups were taken
24 h following 0.30% CCl4. (a) Inhibitory eﬀect of MCE on the
decrease in VDAC mRNA level induced by CCl4 analyzed by RT-
PCR. (b) Inhibitory eﬀect of MCE on the decrease in VDAC protein
level induced by CCl4 analyzed by western blot.
by a metabolic enzyme (cytochrome P450) and could induce
peroxidation of the unsaturated fatty acids of cell membrane,
and lead to membrane injury and leakage of enzymes such
as AST and ALT [23]. In fact, sAST and sALT are the
most sensitive indicators of liver injury, with the extent
of hepatic damage assessed by the serum level of enzymes
released from cytoplasm and especially mitochondria. It
has been demonstrated that ALT enzyme is one of the
indices of the degree of cell membrane damage, whereas
AST is one of the indices of mitochondrial damage since
mitochondria contain 80% of the enzyme [24]. Based on
our results, we speculated that MCE has a protective eﬀect
on both hepatocytes and their mitochondria. This was
confirmed by ultrastructure examination. Protection of liver
mitochondria against hepatocytes injury induced by CCl4
was demonstrated for MCE (150 and 450 mg kg−1).
It is now generally accepted that maintenance of mito-
chondrial membrane potential is necessary for mitochondria
to carry out their functions. In the present work, the eﬀect of
MCE on liver mitochondrial membrane potential in CCl4-
intoxicated mice was assessed. Treatment of mice with CCl4
damaged the liver mitochondria as characterized by the
dissipation of mitochondrial membrane potential which is in
agreement with a previous report [25]. MCE could prevent
the collapse of mitochondrial membrane potential, which
confirmed the suggestion of MCE’s protective eﬀect against
mitochondria deficiency.
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Figure 8: CCl4 could induce peroxidation of the unsaturated fatty acids of cell membrane, and lead to membrane injury, enhance the
leakage of AST, the dissipation of mitochondrial membrane potential, hepatocellular Ca2+ overload and decrease the sensitivity in Ca2+-
induced mitochondrial swelling and other the mRNA and the protein of VDAC’s expressions. Using MCE could prevent all these changes,
that is to say, MCE has hepatoprotective activity and the mechanisms underlying its protective eﬀects may be related to the mitochondrial
protection.
It is very crucial for the cell to maintain cytosolic Ca2+
at very low levels (0.1–0.2 μM) and CCl4 can result in
hepatocellular Ca2+ overload [26], which can activate the
mitochondrial Ca2+ uniporter in the mitochondrial inner
membrane, induce a mitochondrial Ca2+ influx and finally
damage mitochondria [27]. In the examination, we evaluated
the eﬀect of MCE on the intra-mitochondrial Ca2+ content in
the CCl4-intoxicated mice. MCE showed a dose-dependent
suppression of the CCl4-induced intra-mitochondrial Ca2+
overload. This suggested an important relation between the
preserving eﬀect of MCE on mitochondrial calcium home-
ostasis and its protection of liver mitochondria.
Mitochondria isolated from mice livers were used to
assess the eﬀect of MCE on Ca2+-induced liver mitochondria
permeability transition (MPT) to search for the possible
mechanisms of MCE protection of liver mitochondria. Ca2+-
induced liver MPT is a useful model for evaluating the
eﬀects of drugs or other substances on mitochondrial PTP
[28, 29]. MPT could be induced by 100μmol/L Ca2+ in liver
mitochondria freshly isolated from mice. It was also found
that the decreased sensitivity in Ca2+-induced mitochondrial
swelling, induced by CCl4, could be prevented by MCE.
This indicates a protective role of MCE on normal MPT of
mitochondria.
Furthermore, there was accumulating evidence that there
were changes in the levels of expression of the mitochondrial
VDAC, one of the most important proteins on the outer
membrane regarding the process of apoptosis [30–32].
VDAC levels decreased significantly after CCl4 adminis-
tration and pretreatment of MCE could dose-dependently
inhibit the reduction of both transcriptional and transla-
tional levels of VDAC in acute liver injury process, suggesting
that the protective eﬀect of MCE on liver mitochondrial in
mice might be related to an up-regulation of the expression
of mitochondrial VDAC which could be decreased by CCl4.
In conclusion, the results of the present study suggested
that MCE has hepatoprotective activity and the mechanisms
underlying its protective eﬀects may be related to the mito-
chondrial protection and especially the regulation of VDAC
expression (Figure 8). The active components of MCE await
further study.
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